15.1.2025 14:01:01 CET | Thor Medical ASA | Meldepliktig handel for
primærinnsidere

Oslo, Norway, 15 January 2025: Ekornhuset AS, a close associate of chairperson
of the board of Thor Medical ASA, Ludvik Sandnes, has today acquired 200,000
shares in Thor Medical ASA at a price of NOK 2.491 per share.

Primary insider notifications pursuant to the market abuse regulation article 19
are attached.

This information is subject to disclosure requirements pursuant to the EU Market
Abuse Regulation article 5 and the Norwegian Securities Trading Act section
5-12.

KONTAKTER

 * Brede Ellingsæter, CFO, Thor Medical ASA, +47 472 38 440,
   brede.ellingseter@thormedical.com 

OM THOR MEDICAL ASA

Thor Medical is an emerging supplier of radionuclides, primarily alpha particle
emitters, from naturally occurring thorium. Its proprietary production process
requires no irradiation or use of nuclear reactors, and provides reliable,
environmentally friendly, cost-efficient supply of alpha-emitters for the
radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and
listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.

To learn more, visitwww.thormedical.no - https://www.thormedical.no.

VEDLEGG

Last ned som PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18386068/5534/Last%20ned%20som%20
PDF.pdf

20250115 - MAR Form - Ekornhuset AS.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18386068/5533/20250115%20-%20MAR%
20Form%20-%20Ekornhuset%20AS.pdf